Skip to main content
VMD
NASDAQ Industrial Applications And Services

Viemed Healthcare Reports Strong Q1 Revenue Growth and Increased Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$9.5
Mkt Cap
$373.291M
52W Low
$5.93
52W High
$10.18
52W Position info
60% above low
Off High info
6.7% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

VMD sits 60% above its 52-week low of $5.93.

Summary

Viemed Healthcare reported a 27.5% year-over-year revenue increase and a significant boost in operating cash flow for Q1 2026, alongside active share repurchases.


Key Events · Earnings and Guidance · VMD

  • Strong Revenue Growth

    Revenue increased 27.5% year-over-year to $75.4 million, driven by strategic expansion and diversified product offerings.

  • Significant Operating Cash Flow Increase

    Net cash provided by operating activities surged 182.8% year-over-year to $8.1 million, reflecting strong operational performance.

  • Active Share Repurchase Program

    The company repurchased 150,000 common shares for $1.4 million under its 2026 Share Repurchase Program, with 1,780,131 shares remaining available.

  • Net Income Stability with Context

    Net income remained flat year-over-year at $2.6 million, primarily due to a non-recurring gain in the prior year from a ventilator buyback program.


Analysis · VMD · Industrial Applications And Services

Viemed Healthcare's Q1 2026 results confirm the strong performance indicated by recent news, with revenue increasing 27.5% year-over-year to $75.4 million, driven by strategic expansion and diversified offerings. Operating cash flow saw a substantial 182.8% increase to $8.1 million, demonstrating robust core business cash generation. While net income remained flat year-over-year, this was primarily due to a non-recurring gain from a ventilator buyback program in the prior year, suggesting stronger underlying performance in the current period. The company also continued its share repurchase program, buying back 150,000 shares for $1.4 million, signaling confidence and returning capital to shareholders. Viemed remains in compliance with all debt covenants, reinforcing its financial stability.

How filings like this one have moved

In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VMD was trading at $9.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $373.3M. The 52-week trading range was $5.93 to $10.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VMD - Latest Insights

VMD
Aug 20, 2026, 5:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.57
Real-time Price: $9.10 info
Change: +$0.530 (+6%) info
Market Cap: $346.603M info
VMD
Aug 03, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $9.10 info
Change: -$1.90 (-17%) info
Market Cap: $346.603M info
VMD
Aug 03, 2026, 5:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $9.10 info
Change: -$1.90 (-17%) info
Market Cap: $346.603M info
VMD
Aug 03, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $9.10 info
Change: -$1.90 (-17%) info
Market Cap: $346.603M info
VMD
Jun 04, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.84
Real-time Price: $9.10 info
Change: -$0.740 (-8%) info
Market Cap: $346.603M info